Insider Transactions in Q1 2024 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2024
|
Jennifer Jarrett |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+20.73%
|
-
|
|
Feb 07
2024
|
Martin H. Huber Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+25.76%
|
-
|
|
Feb 07
2024
|
Neil Gallagher President, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
47,813
+35.77%
|
-
|
|
Feb 07
2024
|
Keith A. Goldan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,700
+32.71%
|
-
|
|
Feb 07
2024
|
Michael A Metzger Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
146,250
+32.71%
|
-
|
|
Feb 07
2024
|
Pierre Legault |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+20.73%
|
-
|
|
Feb 07
2024
|
Dennis Podlesak |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+19.34%
|
-
|
|
Feb 07
2024
|
Briggs Morrison |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+32.8%
|
-
|
|
Feb 07
2024
|
William Meury |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+20.73%
|
-
|
|
Feb 07
2024
|
Keith Katkin |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+20.73%
|
-
|
|
Jan 31
2024
|
Keith A. Goldan Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
1,183
+20.2%
|
$20,111
$17.42 P/Share
|